Special Issue "Pathology of Urogenital Cancers"
Deadline for manuscript submissions: 31 January 2024 | Viewed by 14382
Interests: prostate cancer; bladder cancer; renal cell carcinoma; carcinogenesis; diagnosis; upper urinary tract tumors; treatment
Interests: pregnancy complications; preeclampsia; preterm birth; ovarian cancer; early marker of pregnancy complications; oxidative stress; chemoresistance
Special Issues, Collections and Topics in MDPI journals
We are pleased to invite you to submit a manuscript to the Special Issue “Pathology of Urologic Cancers”. The incidence of urological malignancies has increased significantly over the past 50 years. Despite advances in medical tumor therapy, the occurrence of chemoresistance and metastatic disease is a common cause of death in patients with urological malignancies. Thus, it is necessary to develop new therapeutic approaches that can improve diagnosis and treatment outcomes. To this aim, we need a better understanding of the molecular changes occurring in urological tumors and the development of molecular biomarkers able to predict tumor behavior and risk of disease recurrence and chemoresistance.
This Special Issue of Cancers, therefore, welcomes original research articles and reviews related to urological malignancies. Communications, mini-reviews, systematic reviews and meta-analyses are also welcome.
We look forward to receiving your contributions.
Prof. Roberta Mazzucchelli
Dr. Giovanni Tossetta
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- prostate cancer
- bladder cancer
- renal cell carcinoma
- testicular cancer
- early diagnosis
- upper urinary tract tumors